drug
nipocalimab
pre_registrationupdated 3mo agoby $JNJ JOHNSON & JOHNSON
community read0 votes
indications
indications
Lupus
all catalysts(0)
nothing on the calendar yet
Trials studying nipocalimab
- phase1A Study to Assess Nipocalimab Concentrations in Breast Milk of Healthy Lactating Women
- phase3Nipocalimab in Moderate to Severe Sjogren's Disease
- phase3Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis
- phase3A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
- phase3A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
- phase3A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)
- phase3A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
- phase2A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies
News(2)
- Sensorion axes hearing loss program; Novartis' biomarker data in muscular dystrophyPlus, news about Imaavy. 👂 Sensorion selects one hearing loss program, axes another: The biotech is ending the development of SENS-501 for OTOF-related hearing loss following a “strategic review.”…endpoints · 2mo ago
- J&J looks to widen Imaavy’s use; $300M backs rare disease drug launchNew data suggest Imaavy could be an effective treatment for autoimmune anemia. Elsewhere, Enliven detailed data for a Merck leukemia rival and MBX hyperparathyroidism drug hit its goal.biopharma_dive · 2mo ago
Data sources
last refreshed 7m ago
Found something off?
comments(0)
5-min edit window · permanent after that